CIMT Testing for Subclinical Atherosclerosis Detection
CIMT detects early arterial changes, but works best for intermediate-risk patients.
Miriam Osei-Bonsu
Section
8 stories in Advanced Assays.
CIMT detects early arterial changes, but works best for intermediate-risk patients.
Sequencing finds inherited risks and drug responses, but not all results guide care.
Early screening can catch bone loss in younger adults with specific risk factors.
Reproducibility problems undermine the clinical value of current consumer microbiome tests.
Genes control how fast your body processes common drugs, not standard dosing.
A single fitness test predicts mortality risk as strongly as smoking or diabetes.
Calcium imaging directly measures artery plaque burden better than risk calculators.
Standard cholesterol panels miss particle-level risks that advanced testing can reveal.